Afinitor Everolimus — Highmark
6 indications indexed for this drug.
- Advanced Renal Cell Carcinoma RccView coverage criteria
- Postmenopausal Hormone Receptor Positive Her2 Negative AdvanView coverage criteria
- Progressive Neuroendocrine Tumors Of Pancreatic Origin PnetView coverage criteria
- Progressive Well Differentiated Non Functional NeuroendocrinView coverage criteria
- Renal Angiomyolipoma And Tuberous Sclerosis Complex Tsc NotView coverage criteria
- Tuberous Sclerosis Complex Tsc With Subependymal Giant CellView coverage criteria